• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chemo-proteomics exploration of HDAC degradability by small molecule degraders.通过小分子降解剂对 HDAC 降解能力的化学生物组学探索。
Cell Chem Biol. 2021 Oct 21;28(10):1514-1527.e4. doi: 10.1016/j.chembiol.2021.07.002. Epub 2021 Jul 26.
2
PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes.PROTAC 介导的核心抑制复合物中 I 类组蛋白去乙酰化酶的降解。
Chem Commun (Camb). 2020 Apr 21;56(32):4476-4479. doi: 10.1039/d0cc01485k.
3
Advances in the Design and Development of PROTAC-mediated HDAC Degradation.PROTAC介导的组蛋白去乙酰化酶降解的设计与开发进展
Curr Top Med Chem. 2022 Mar 4;22(5):408-424. doi: 10.2174/1568026621666211015092047.
4
Development of the first small molecule histone deacetylase 6 (HDAC6) degraders.首个小分子组蛋白去乙酰化酶6(HDAC6)降解剂的研发。
Bioorg Med Chem Lett. 2018 Aug 1;28(14):2493-2497. doi: 10.1016/j.bmcl.2018.05.057. Epub 2018 May 30.
5
Designing HDAC-PROTACs: lessons learned so far.设计 HDAC-PROTACs:迄今为止的经验教训。
Future Med Chem. 2022 Jan;14(3):143-166. doi: 10.4155/fmc-2021-0206. Epub 2021 Dec 24.
6
Innovative Strategies for Selective Inhibition of Histone Deacetylases.创新策略:选择性抑制组蛋白去乙酰化酶。
Cell Chem Biol. 2016 Jul 21;23(7):759-768. doi: 10.1016/j.chembiol.2016.06.011.
7
Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders.小分子配体对 von Hippel-Lindau (VHL) E3 连接酶的发现及其作为抑制剂和 PROTAC 降解剂的应用。
Chem Soc Rev. 2022 Oct 3;51(19):8216-8257. doi: 10.1039/d2cs00387b.
8
Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation.锌依赖型组蛋白去乙酰化酶的蛋白酶体降解:涉及的 E3 连接酶和设计的可促进降解的 PROTACs。
Molecules. 2021 Sep 15;26(18):5606. doi: 10.3390/molecules26185606.
9
Optimization of Class I Histone Deacetylase PROTACs Reveals that HDAC1/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells.优化 I 类组蛋白去乙酰化酶 PROTAC 揭示了 HDAC1/2 的降解对于诱导癌细胞凋亡和细胞停滞至关重要。
J Med Chem. 2022 Apr 14;65(7):5642-5659. doi: 10.1021/acs.jmedchem.1c02179. Epub 2022 Mar 16.
10
Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitors.用于鉴定和表征小分子组蛋白脱乙酰酶抑制剂的分析技术。
Drug Discov Today Technol. 2015 Nov;18:24-8. doi: 10.1016/j.ddtec.2015.10.006. Epub 2015 Nov 3.

引用本文的文献

1
Development of Dual Aurora-A and Aurora-B Degrading PROTACs for -Amplified Neuroblastoma.用于扩增型神经母细胞瘤的双极光激酶A和极光激酶B降解PROTAC的开发。
ChemMedChem. 2025 Mar 3;20(5). doi: 10.1002/cmdc.202400703. Epub 2024 Nov 20.
2
Unveiling the hidden interactome of CRBN molecular glues.揭示CRBN分子胶的隐藏相互作用组。
Nat Commun. 2025 Jul 24;16(1):6831. doi: 10.1038/s41467-025-62099-w.
3
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function.一种潜在血液系统恶性肿瘤疗法的发现:靶向非酶功能的选择性强效组蛋白去乙酰化酶7(HDAC7)蛋白酶体靶向嵌合体降解剂
Acta Pharm Sin B. 2025 Mar;15(3):1659-1679. doi: 10.1016/j.apsb.2025.01.021. Epub 2025 Jan 30.
4
Development of Ethyl-Hydrazide-Based Selective Histone Deacetylase 6 (HDAC6) PROTACs.基于乙基酰肼的选择性组蛋白去乙酰化酶6(HDAC6)PROTACs的研发
ACS Med Chem Lett. 2025 Feb 19;16(3):487-495. doi: 10.1021/acsmedchemlett.5c00033. eCollection 2025 Mar 13.
5
Replacing a Cereblon Ligand by a DDB1 and CUL4 Associated Factor 11 (DCAF11) Recruiter Converts a Selective Histone Deacetylase 6 PROTAC into a Pan-Degrader.用一种DDB1和CUL4相关因子11(DCAF11)招募剂取代 Cereblon配体,可将一种选择性组蛋白去乙酰化酶6 PROTAC转化为一种泛降解剂。
ChemMedChem. 2025 May 19;20(10):e202500035. doi: 10.1002/cmdc.202500035. Epub 2025 Mar 24.
6
UM171 glues asymmetric CRL3-HDAC1/2 assembly to degrade CoREST corepressors.UM171 结合不对称的CRL3-HDAC1/2 组装体以降解 CoREST 共抑制因子。
Nature. 2025 Mar;639(8053):232-240. doi: 10.1038/s41586-024-08532-4. Epub 2025 Feb 12.
7
Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders.首款靶向FEM1B的组蛋白去乙酰化酶降解剂的研发。
J Med Chem. 2025 Jan 23;68(2):1824-1843. doi: 10.1021/acs.jmedchem.4c02569. Epub 2025 Jan 13.
8
Cereblon-recruiting proteolysis targeting chimeras (PROTACs) can determine the selective degradation of HDAC1 over HDAC3.cereblon 招募的蛋白水解靶向嵌合体(PROTACs)可特异性地使 HDAC1 降解,而不降解 HDAC3。
Chem Commun (Camb). 2024 Nov 21;60(94):13879-13882. doi: 10.1039/d4cc05138f.
9
Unveiling the hidden interactome of CRBN molecular glues with chemoproteomics.利用化学蛋白质组学揭示CRBN分子胶的隐藏相互作用组。
bioRxiv. 2024 Oct 4:2024.09.11.612438. doi: 10.1101/2024.09.11.612438.
10
Extrapolating Lessons from Targeted Protein Degradation to Other Proximity-Inducing Drugs.从靶向蛋白降解中推断出其他邻近诱导药物的经验。
ACS Chem Biol. 2024 Oct 18;19(10):2089-2102. doi: 10.1021/acschembio.4c00191. Epub 2024 Sep 12.

本文引用的文献

1
Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development.绘制可降解激酶组图谱为加快降解剂开发提供资源。
Cell. 2020 Dec 10;183(6):1714-1731.e10. doi: 10.1016/j.cell.2020.10.038. Epub 2020 Dec 3.
2
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma.神经母细胞瘤中的组蛋白去乙酰化酶和组蛋白去乙酰化酶抑制剂
Front Cell Dev Biol. 2020 Oct 7;8:578770. doi: 10.3389/fcell.2020.578770. eCollection 2020.
3
Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors.基于蛋白质组学的选择性抑制剂鉴定 DUB 底物。
Cell Chem Biol. 2021 Jan 21;28(1):78-87.e3. doi: 10.1016/j.chembiol.2020.09.005. Epub 2020 Oct 1.
4
Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC).通过蛋白酶体靶向嵌合体(PROTAC)诱导组蛋白去乙酰化酶 3(HDAC3)的蛋白降解。
Eur J Med Chem. 2020 Dec 15;208:112800. doi: 10.1016/j.ejmech.2020.112800. Epub 2020 Sep 6.
5
HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation.HDAC6 通过类似聚集物的机制介导 NLRP3 和 pyrin 炎症小体的激活。
Science. 2020 Sep 18;369(6510). doi: 10.1126/science.aas8995.
6
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs.发现组蛋白去乙酰化酶 3(HDAC3)特异性 PROTAC 分子。
Chem Commun (Camb). 2020 Aug 25;56(68):9866-9869. doi: 10.1039/d0cc03243c.
7
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs).羟胺酸固载树脂(HAIRs):双靶标 HDAC 抑制剂和 HDAC 降解剂(PROTACs)的合成。
Angew Chem Int Ed Engl. 2020 Dec 7;59(50):22494-22499. doi: 10.1002/anie.202006725. Epub 2020 Oct 9.
8
Dichotomous engagement of HDAC3 activity governs inflammatory responses.HDAC3活性的二元参与调控炎症反应。
Nature. 2020 Aug;584(7820):286-290. doi: 10.1038/s41586-020-2576-2. Epub 2020 Aug 5.
9
An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells.原发性人 T 细胞中亲电半胱氨酸相互作用的活性导向图谱。
Cell. 2020 Aug 20;182(4):1009-1026.e29. doi: 10.1016/j.cell.2020.07.001. Epub 2020 Jul 29.
10
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.三十年 HDAC 抑制剂:2020 年的新视角和新认识。
J Med Chem. 2020 Nov 12;63(21):12460-12484. doi: 10.1021/acs.jmedchem.0c00830. Epub 2020 Jul 16.

通过小分子降解剂对 HDAC 降解能力的化学生物组学探索。

Chemo-proteomics exploration of HDAC degradability by small molecule degraders.

机构信息

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

出版信息

Cell Chem Biol. 2021 Oct 21;28(10):1514-1527.e4. doi: 10.1016/j.chembiol.2021.07.002. Epub 2021 Jul 26.

DOI:10.1016/j.chembiol.2021.07.002
PMID:34314730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9339248/
Abstract

Targeted protein degradation refers to the use of small molecules that recruit a ubiquitin ligase to a target protein for ubiquitination and subsequent proteasome-dependent degradation. While degraders have been developed for many targets, key questions regarding degrader development and the consequences of acute pharmacological degradation remain, specifically for targets that exist in obligate multi-protein complexes. Here, we synthesize a pan-histone deacetylase (HDAC) degrader library for the chemo-proteomic exploration of acute degradation of a key class of chromatin-modifying enzymes. Using chemo-proteomics, we not only map the degradability of the zinc-dependent HDAC family identifying leads for targeting HDACs 1-8 and 10 but also explore important aspects of degrading epigenetic enzymes. We discover cell line-driven target specificity and that HDAC degradation often results in collateral loss of HDAC-containing repressive complexes. These findings potentially offer a new mechanism toward controlling chromatin structure, and our resource will facilitate accelerated degrader design and development for HDACs.

摘要

靶向蛋白降解是指利用小分子将泛素连接酶招募到靶蛋白上进行泛素化,随后被蛋白酶体依赖的降解。虽然已经开发出许多针对特定靶点的降解剂,但关于降解剂的开发以及急性药理学降解的后果,特别是对于存在于必需多蛋白复合物中的靶点,仍存在一些关键问题。在这里,我们合成了一个泛组蛋白去乙酰化酶(HDAC)降解剂文库,用于对一类关键染色质修饰酶的急性降解进行化学蛋白质组学研究。通过化学蛋白质组学,我们不仅可以对锌依赖性 HDAC 家族的可降解性进行绘图,从而确定靶向 HDACs 1-8 和 10 的先导化合物,还可以探索降解表观遗传酶的重要方面。我们发现细胞系驱动的靶标特异性,并且 HDAC 降解通常会导致包含 HDAC 的抑制性复合物的副产物丢失。这些发现可能为控制染色质结构提供了一种新的机制,并且我们的资源将有助于加速 HDAC 的降解剂设计和开发。